| scholarly article | Q13442814 |
| P50 | author | Glyn Lewis | Q5572854 |
| Joseph Hayes | Q86116312 | ||
| Ian Chi Kei Wong | Q43194222 | ||
| P2093 | author name string | David P J Osborn | |
| Christina Dalman | |||
| Andreas Lundin | |||
| Susanne Wicks | |||
| P2860 | cites work | Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia | Q89256921 |
| Metformin: An Update | Q22241145 | ||
| NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development | Q28205016 | ||
| Genome-wide association analysis identifies 13 new risk loci for schizophrenia | Q28297287 | ||
| Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study | Q28548023 | ||
| Refugee migration and risk of schizophrenia and other non-affective psychoses: cohort study of 1.3 million people in Sweden | Q28602605 | ||
| Immune system and glucose metabolism interaction in schizophrenia: a chicken-egg dilemma | Q30574207 | ||
| The Stockholm non-affective psychoses study (snaps): the importance of including out-patient data in incidence studies. | Q33514079 | ||
| Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study | Q33717374 | ||
| Current perspectives on statins | Q33818381 | ||
| A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly | Q33962657 | ||
| Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis | Q34161953 | ||
| Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program. | Q35159804 | ||
| Calcium channel blockers: an update | Q35620923 | ||
| Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer's disease | Q36584677 | ||
| A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development | Q37271237 | ||
| L‐type calcium channels and psychiatric disorders: A brief review | Q37795701 | ||
| Adverse effects of statins - myths and reality | Q38259952 | ||
| Metformin: repurposing opportunities for cognitive and mood dysfunction | Q38282329 | ||
| The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months | Q38404794 | ||
| Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder | Q38735900 | ||
| BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. | Q38826206 | ||
| Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden. | Q40131530 | ||
| Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses | Q40368967 | ||
| Lipid and C-reactive protein levels, cardiovascular disease risk factors and simvastatin treatment in Brazilian individuals. | Q43190405 | ||
| Young cases of schizophrenia identified in a national inpatient register--are the diagnoses valid? | Q43518430 | ||
| In vitro P-glycoprotein affinity for atypical and conventional antipsychotics | Q44006829 | ||
| Chronic treatment with simvastatin upregulates muscarinic M1/4 receptor binding in the rat brain. | Q46577115 | ||
| Role of voltage-gated L-type Ca2+ channel isoforms for brain function. | Q48392323 | ||
| Effects of high dose of simvastatin on levels of dopamine and its reuptake in prefrontal cortex and striatum among SD rats | Q48415345 | ||
| The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats | Q49065735 | ||
| Adjunctive therapy with statins in schizophrenia patients: A meta-analysis and implications | Q50085577 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hospitalization | Q3140971 |
| serious mental illness | Q19365224 | ||
| P304 | page(s) | 382-390 | |
| P577 | publication date | 2019-04-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness | |
| P478 | volume | 76 |
| Q100697180 | Associations between statin use and suicidality, depression, anxiety, and seizures: a Swedish total-population cohort study |
| Q91152111 | Long-read sequencing reveals the complex splicing profile of the psychiatric risk gene CACNA1C in human brain |
| Q101165866 | Nimodipine improves cortical efficiency during working memory in healthy subjects |
| Q91522792 | Pharmacoepidemiology research: delivering evidence about drug safety and effectiveness in mental health |
| Q96834102 | Signature-based approaches for informed drug repurposing: targeting CNS disorders |
| Q92886442 | The relationship between antihypertensive medications and mood disorders: analysis of linked healthcare data for 1.8 million patients |
| Q95579830 | Treating psychiatric symptoms and disorders with non-psychotropic medications |
Search more.